UroGen Pharma Ltd. (URGN) NASDAQ
$14.53 0.16 (1.11%)
Market Cap: $495.79M
As of 04/23/24 04:00 PM EDT. Market closed.
UroGen Pharma Ltd. (URGN)
NASDAQ
$14.53
0.16 (1.11%)
Market Cap: $495.79M
As of 04/23/24 04:00 PM EDT. Market closed.
Add to Portfolio
urogen pharma ltd. (nasdaq:urgn) is a clinical-stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology, with a focus on uro-oncology. the company has developed rtgel™, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. urogen pharma's ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Elizabeth Barrett
Full Time Employees
206
CEO Compensation (Base)
$610,200
CEO Compensation (Total)
$5.95M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Elizabeth Barrett
Full Time Employees
206
CEO Compensation (Base)
$610,200
CEO Compensation (Total)
$5.95M
URL
Address
Raanana, 9 Hataasiya St, 4365007.
PRICE CHART FOR UROGEN PHARMA LTD
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$14.37
Days Range
$14.11 - $14.83
52 week range
$8.69 - $24.13
Volume
216,766
Avg. Volume (30 days)
320,053
Market Cap
$495.79M
Dividend Yield
-
P/E
-
Shares Outstanding
34,122,087
Open
-
Previous Close
$14.37
Days Range
$14.11 - $14.83
52 week range
$8.69 - $24.13
Volume
216,766
Avg. Volume (30 days)
320,053
Market Cap
$495.79M
Dividend Yield
-
P/E
-
Shares Outstanding
34,122,087
FINANCIAL STATEMENTS FOR UROGEN PHARMA LTD
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR UROGEN PHARMA LTD
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Schoenberg Mark | Chief Medical Officer | Mar 18, 2024 | Sale | $14.05 | 12,000 | 168,600 | 139,437 | Mar 20, 2024, 04:38 PM |
| Smith Jason Drew | General Counsel | Feb 01, 2024 | Sale | $15.78 | 4,993 | 78,790 | 23,414 | Feb 05, 2024, 09:16 PM |
| Schoenberg Mark | Chief Medical Officer | Feb 01, 2024 | Sale | $15.78 | 3,789 | 59,790 | 151,437 | Feb 05, 2024, 09:15 PM |
| Smith Jason Drew | General Counsel | Jan 31, 2024 | Sale | $15.74 | 4,993 | 78,590 | 23,414 | Feb 02, 2024, 07:12 PM |
| Schoenberg Mark | Chief Medical Officer | Jan 31, 2024 | Sale | $15.74 | 3,789 | 59,639 | 151,437 | Feb 02, 2024, 07:07 PM |
| Smith Jason Drew | General Counsel | Aug 31, 2023 | Sale | $18.01 | 3,800 | 68,438 | 18,407 | Sep 05, 2023, 04:28 PM |
| Cohen Fred E | Director | Jul 26, 2023 | Option Exercise | $9.54 | 69,339 | 661,494 | 69,339 | Jul 28, 2023, 06:06 PM |
| Nussbaum Ran | Director | Jun 06, 2022 | Option Exercise | $5.00 | 1,030 | 5,150 | 1,434,958 | Feb 28, 2023, 12:29 PM |
| Nussbaum Ran | Director | Oct 21, 2022 | Option Exercise | $5.94 | 47,999 | 285,114 | 1,485,168 | Feb 28, 2023, 12:23 PM |
| Nussbaum Ran | Director | Jun 16, 2022 | Option Exercise | $5.00 | 2,211 | 11,055 | 1,437,169 | Feb 28, 2023, 12:21 PM |
| Smith Jason Drew | General Counsel | Jan 31, 2023 | Sale | $10.12 | 1,636 | 16,556 | 13,873 | Feb 02, 2023, 01:04 PM |
| Schoenberg Mark | Chief Medical Officer | Jan 31, 2023 | Sale | $10.12 | 1,900 | 19,228 | 148,560 | Feb 02, 2023, 01:02 PM |
| Schoenberg Mark | Chief Medical Officer | Jan 20, 2023 | Option Exercise | $5.00 | 122,677 | 613,385 | 146,627 | Jan 23, 2023, 07:10 PM |
| Schoenberg Mark | Chief Medical Officer | Oct 31, 2022 | Sale | $11.85 | 258 | 3,057 | 23,950 | Nov 02, 2022, 04:31 PM |
| Nussbaum Ran | Director | Oct 21, 2022 | Option Exercise | $5.94 | 47,999 | 285,114 | 1,481,927 | Oct 25, 2022, 04:57 PM |
| Belldegrun Arie | Director | Sep 14, 2022 | Option Exercise | $5.00 | 160,000 | 800,000 | 408,693 | Sep 16, 2022, 03:13 PM |
| Belldegrun Arie | Director | Aug 31, 2022 | Option Exercise | $5.00 | 3,241 | 16,205 | 248,693 | Sep 02, 2022, 11:40 AM |
| Smith Jason Drew | General Counsel | Aug 31, 2022 | Sale | $7.21 | 3,606 | 25,999 | 12,176 | Sep 02, 2022, 11:40 AM |
| Nussbaum Ran | Director | Jun 06, 2022 | Option Exercise | $5.00 | 1,030 | 5,150 | 1,433,928 | Aug 25, 2022, 03:25 PM |
| Schoenberg Mark | Chief Medical Officer | Aug 01, 2022 | Sale | $7.81 | 259 | 2,023 | 23,708 | Aug 25, 2022, 03:25 PM |
| Schoenberg Mark | Chief Medical Officer | Apr 30, 2022 | Sale | $6.62 | 254 | 1,681 | 23,467 | May 03, 2022, 05:19 PM |
| Smith Jason Drew | General Counsel | Jan 31, 2022 | Sale | $7.58 | 414 | 3,138 | 7,449 | Feb 02, 2022, 04:35 PM |
| Henderson Molly | Chief Financial Officer | Jan 31, 2022 | Sale | $7.58 | 331 | 2,509 | 5,248 | Feb 02, 2022, 04:34 PM |
| Schoenberg Mark | Chief Medical Officer | Jan 31, 2022 | Sale | $7.58 | 1,374 | 10,415 | 23,221 | Feb 02, 2022, 04:33 PM |
| Barrett Elizabeth A. | Chief Executive Officer | Jan 31, 2022 | Sale | $7.58 | 8,195 | 62,118 | 308,358 | Feb 02, 2022, 04:32 PM |
| Schoenberg Mark | Chief Medical Officer | Jan 26, 2022 | Sale | $8.09 | 111 | 898 | 22,095 | Jan 28, 2022, 04:29 PM |
| Barrett Elizabeth A. | Chief Executive Officer | Jan 04, 2022 | Sale | $9.15 | 46,968 | 429,757 | 298,220 | Jan 07, 2022, 08:38 AM |
| Smith Jason Drew | General Counsel | Nov 30, 2021 | Sale | $12.03 | 3,803 | 45,750 | 7,030 | Dec 02, 2021, 01:16 PM |
| Henderson Molly | Chief Financial Officer | Nov 30, 2021 | Sale | $12.03 | 2,587 | 31,122 | 4,913 | Dec 02, 2021, 01:15 PM |
| Schoenberg Mark | Chief Medical Officer | Nov 18, 2021 | Buy | $13.10 | 160 | 2,096 | 21,997 | Nov 19, 2021, 03:05 PM |
| Schoenberg Mark | Chief Medical Officer | Nov 01, 2021 | Sale | $17.16 | 258 | 4,427 | 21,837 | Nov 02, 2021, 03:45 PM |
| Schoenberg Mark | Chief Medical Officer | Oct 27, 2021 | Sale | $16.32 | 107 | 1,746 | 21,595 | Oct 28, 2021, 02:04 PM |
| Schoenberg Mark | Chief Medical Officer | Aug 02, 2021 | Sale | $15.64 | 243 | 3,801 | 21,494 | Aug 03, 2021, 07:07 PM |
| Schoenberg Mark | Chief Medical Officer | Jul 26, 2021 | Sale | $15.30 | 103 | 1,576 | 20,821 | Jul 28, 2021, 09:11 AM |
| Belldegrun Arie | Director | Mar 26, 2021 | Option Exercise | $5.00 | 3,241 | 16,205 | 245,452 | Jun 09, 2021, 01:47 PM |
| Nussbaum Ran | Director | Mar 25, 2021 | Option Exercise | $5.00 | 1,030 | 5,150 | 1,431,717 | Jun 09, 2021, 01:46 PM |
| Nussbaum Ran | Director | Mar 25, 2021 | Option Exercise | $5.00 | 2,211 | 11,055 | 1,433,928 | Jun 09, 2021, 01:42 PM |
| Barrett Elizabeth A. | Chief Executive Officer | May 19, 2021 | Option Exercise | $17.51 | 3,425 | 59,968 | 240,739 | May 21, 2021, 01:44 PM |
| Henderson Molly | Chief Financial Officer | May 17, 2021 | Buy | $15.85 | 2,500 | 39,625 | 2,500 | May 18, 2021, 11:36 AM |
| Smith Jason Drew | General Counsel | May 17, 2021 | Buy | $15.71 | 2,500 | 39,275 | 2,500 | May 18, 2021, 11:35 AM |
| Schoenberg Mark | Chief Medical Officer | Apr 30, 2021 | Sale | $20.00 | 243 | 4,860 | 21,132 | May 04, 2021, 01:58 PM |
| Schoenberg Mark | Chief Medical Officer | Apr 26, 2021 | Sale | $19.63 | 89 | 1,747 | 20,875 | Apr 27, 2021, 01:44 PM |
| Belldegrun Arie | Director | Mar 24, 2021 | Option Exercise | $5.00 | 3,241 | 16,205 | 245,452 | Apr 22, 2021, 05:19 PM |
| Nussbaum Ran | Director | Mar 24, 2021 | Option Exercise | $5.00 | 1,030 | 5,150 | 1,465,199 | Apr 22, 2021, 05:18 PM |
| Schoenberg Mark | Chief Medical Officer | Jan 31, 2021 | Sale | $22.07 | 1,076 | 23,747 | 20,755 | Feb 02, 2021, 02:53 PM |
| Schoenberg Mark | Chief Medical Officer | Jan 26, 2021 | Sale | $22.12 | 100 | 2,212 | 19,831 | Jan 26, 2021, 05:20 PM |
| Barrett Elizabeth A. | Chief Executive Officer | Dec 14, 2020 | Buy | $18.50 | 10,000 | 185,000 | 229,117 | Dec 15, 2020, 05:27 PM |
| Schoenberg Mark | Chief Medical Officer | Dec 04, 2020 | Sale | $19.85 | 662 | 13,141 | 19,723 | Dec 07, 2020, 03:59 PM |
| Schoenberg Mark | Chief Medical Officer | Oct 26, 2020 | Sale | $20.95 | 101 | 2,116 | 19,343 | Oct 28, 2020, 02:12 PM |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | Oct 15, 2020 | Sale | $21.77 | 2,400 | 52,248 | 11,829 | Oct 16, 2020, 03:41 PM |
| Schoenberg Mark | Chief Medical Officer | Sep 04, 2020 | Sale | $20.20 | 348 | 7,030 | 19,236 | Sep 08, 2020, 04:48 PM |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | Sep 01, 2020 | Sale | $22.82 | 509 | 11,615 | 7,888 | Sep 01, 2020, 02:37 PM |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | Jul 27, 2020 | Sale | $23.51 | 141 | 3,315 | 7,355 | Jul 28, 2020, 05:34 PM |
| Schoenberg Mark | Chief Medical Officer | Jul 27, 2020 | Sale | $23.51 | 70 | 1,646 | 18,543 | Jul 28, 2020, 05:32 PM |
| Schoenberg Mark | Chief Medical Officer | Jun 04, 2020 | Sale | $27.51 | 349 | 9,602 | 18,404 | Jun 05, 2020, 02:31 PM |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | May 20, 2020 | Sale | $25.07 | 358 | 8,975 | 7,079 | May 20, 2020, 04:44 PM |
| Schoenberg Mark | Chief Medical Officer | Apr 27, 2020 | Sale | $24.35 | 70 | 1,705 | 17,711 | Apr 28, 2020, 01:53 PM |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | Apr 27, 2020 | Sale | $24.35 | 141 | 3,433 | 6,396 | Apr 28, 2020, 01:51 PM |
| Mullennix Stephen | Chief Operating Officer | Apr 27, 2020 | Sale | $24.35 | 145 | 3,531 | 10,084 | Apr 28, 2020, 01:43 PM |
| Schoenberg Mark | Chief Medical Officer | Mar 04, 2020 | Option Exercise | $29.50 | 345 | 10,178 | 17,573 | Mar 04, 2020, 05:28 PM |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | Feb 20, 2020 | Sale | $29.68 | 360 | 10,685 | 6,120 | Feb 24, 2020, 04:53 PM |
| Mullennix Stephen | Chief Operating Officer | Feb 14, 2020 | Sale | $28.04 | 612 | 17,160 | 9,812 | Feb 18, 2020, 02:33 PM |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | Jan 27, 2020 | Sale | $29.28 | 667 | 19,530 | 4,438 | Jan 28, 2020, 05:15 PM |
| Mullennix Stephen | Chief Operating Officer | Jan 27, 2020 | Sale | $29.26 | 684 | 20,014 | 8,665 | Jan 28, 2020, 05:14 PM |
| Schoenberg Mark | Chief Medical Officer | Jan 27, 2020 | Sale | $29.15 | 322 | 9,386 | 9,177 | Jan 28, 2020, 05:10 PM |
| Schoenberg Mark | Chief Medical Officer | Dec 04, 2019 | Option Exercise | $31.69 | 343 | 10,870 | 8,666 | Dec 05, 2019, 01:44 PM |
| Barrett Elizabeth A. | Chief Executive Officer | Nov 21, 2019 | Buy | $28.00 | 7,530 | 210,840 | 16,548 | Nov 22, 2019, 03:34 PM |
| Barrett Elizabeth A. | Chief Executive Officer | Nov 20, 2019 | Buy | $28.00 | 7,470 | 209,160 | 9,018 | Nov 22, 2019, 01:35 PM |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | Nov 20, 2019 | Sale | $28.41 | 354 | 10,057 | 3,439 | Nov 22, 2019, 01:29 PM |
| Schoenberg Mark | Chief Medical Officer | Nov 19, 2019 | Buy | $28.17 | 1,960 | 55,213 | 7,967 | Nov 21, 2019, 08:49 PM |
| Barrett Elizabeth A. | Chief Executive Officer | Nov 15, 2019 | Buy | $26.00 | 1,548 | 40,248 | 1,548 | Nov 18, 2019, 07:32 PM |
| Mullennix Stephen | Chief Operating Officer | Nov 14, 2019 | Sale | $26.00 | 608 | 15,806 | 7,683 | Nov 18, 2019, 04:04 PM |
| Schoenberg Mark | Chief Medical Officer | Sep 04, 2019 | Sale | $33.92 | 343 | 11,635 | 6,007 | Sep 06, 2019, 09:27 AM |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | Aug 20, 2019 | Sale | $33.07 | 1,416 | 46,827 | 2,751 | Aug 22, 2019, 01:31 PM |
| Mullennix Stephen | Chief Operating Officer | Aug 15, 2019 | Sale | $31.65 | 608 | 19,243 | 6,532 | Aug 16, 2019, 03:38 PM |
| Schoenberg Mark | Chief Medical Officer | Jun 04, 2019 | Option Exercise | $35.05 | 343 | 12,022 | 5,309 | Jun 06, 2019, 06:21 PM |
| Mullennix Stephen | Chief Operating Officer | May 14, 2019 | Sale | $37.98 | 608 | 23,092 | 5,381 | May 16, 2019, 06:20 PM |
| Belldegrun Arie | Director | Mar 27, 2019 | Option Exercise | $4.02 | 128,000 | 514,560 | 212,211 | Mar 28, 2019, 04:52 PM |
| Schoenberg Mark | Chief Medical Officer | Mar 21, 2019 | Buy | $37.01 | 272 | 10,066 | 4,610 | Mar 22, 2019, 07:42 PM |
| Cohen Fred E | Director | Feb 06, 2019 | Option Exercise | $16.99 | 15,000 | 254,850 | 15,000 | Mar 22, 2019, 07:41 PM |
| Schoenberg Mark | Chief Medical Officer | Mar 06, 2019 | Sale | $37.30 | 1,991 | 74,264 | 4,338 | Mar 07, 2019, 09:46 PM |
| Mullennix Stephen | Chief Operating Officer | Feb 14, 2019 | Sale | $37.30 | 2,804 | 104,589 | 4,230 | Mar 07, 2019, 09:44 PM |
| ProQuest Investments IV, L.P. | 10% Owner | Nov 28, 2017 | Sale | $40.51 | 177,807 | 7,202,961 | 1,242,031 | Nov 29, 2017, 05:07 PM |
| ProQuest Investments IV, L.P. | 10% Owner | Nov 27, 2017 | Sale | $41.12 | 31,491 | 1,294,910 | 1,419,838 | Nov 29, 2017, 05:07 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Schoenberg Mark | Chief Medical Officer | 03/18/2024 | 168,600 |
| Smith Jason Drew | General Counsel | 02/01/2024 | 78,790 |
| Schoenberg Mark | Chief Medical Officer | 02/01/2024 | 59,790 |
| Smith Jason Drew | General Counsel | 01/31/2024 | 78,590 |
| Schoenberg Mark | Chief Medical Officer | 01/31/2024 | 59,639 |
| Smith Jason Drew | General Counsel | 08/31/2023 | 68,438 |
| Cohen Fred E | Director | 07/26/2023 | 661,494 |
| Nussbaum Ran | Director | 06/06/2022 | 5,150 |
| Nussbaum Ran | Director | 10/21/2022 | 285,114 |
| Nussbaum Ran | Director | 06/16/2022 | 11,055 |
| Smith Jason Drew | General Counsel | 01/31/2023 | 16,556 |
| Schoenberg Mark | Chief Medical Officer | 01/31/2023 | 19,228 |
| Schoenberg Mark | Chief Medical Officer | 01/20/2023 | 613,385 |
| Schoenberg Mark | Chief Medical Officer | 10/31/2022 | 3,057 |
| Nussbaum Ran | Director | 10/21/2022 | 285,114 |
| Belldegrun Arie | Director | 09/14/2022 | 800,000 |
| Belldegrun Arie | Director | 08/31/2022 | 16,205 |
| Smith Jason Drew | General Counsel | 08/31/2022 | 25,999 |
| Nussbaum Ran | Director | 06/06/2022 | 5,150 |
| Schoenberg Mark | Chief Medical Officer | 08/01/2022 | 2,023 |
| Schoenberg Mark | Chief Medical Officer | 04/30/2022 | 1,681 |
| Smith Jason Drew | General Counsel | 01/31/2022 | 3,138 |
| Henderson Molly | Chief Financial Officer | 01/31/2022 | 2,509 |
| Schoenberg Mark | Chief Medical Officer | 01/31/2022 | 10,415 |
| Barrett Elizabeth A. | Chief Executive Officer | 01/31/2022 | 62,118 |
| Schoenberg Mark | Chief Medical Officer | 01/26/2022 | 898 |
| Barrett Elizabeth A. | Chief Executive Officer | 01/04/2022 | 429,757 |
| Smith Jason Drew | General Counsel | 11/30/2021 | 45,750 |
| Henderson Molly | Chief Financial Officer | 11/30/2021 | 31,122 |
| Schoenberg Mark | Chief Medical Officer | 11/18/2021 | 2,096 |
| Schoenberg Mark | Chief Medical Officer | 11/01/2021 | 4,427 |
| Schoenberg Mark | Chief Medical Officer | 10/27/2021 | 1,746 |
| Schoenberg Mark | Chief Medical Officer | 08/02/2021 | 3,801 |
| Schoenberg Mark | Chief Medical Officer | 07/26/2021 | 1,576 |
| Belldegrun Arie | Director | 03/26/2021 | 16,205 |
| Nussbaum Ran | Director | 03/25/2021 | 5,150 |
| Nussbaum Ran | Director | 03/25/2021 | 11,055 |
| Barrett Elizabeth A. | Chief Executive Officer | 05/19/2021 | 59,968 |
| Henderson Molly | Chief Financial Officer | 05/17/2021 | 39,625 |
| Smith Jason Drew | General Counsel | 05/17/2021 | 39,275 |
| Schoenberg Mark | Chief Medical Officer | 04/30/2021 | 4,860 |
| Schoenberg Mark | Chief Medical Officer | 04/26/2021 | 1,747 |
| Belldegrun Arie | Director | 03/24/2021 | 16,205 |
| Nussbaum Ran | Director | 03/24/2021 | 5,150 |
| Schoenberg Mark | Chief Medical Officer | 01/31/2021 | 23,747 |
| Schoenberg Mark | Chief Medical Officer | 01/26/2021 | 2,212 |
| Barrett Elizabeth A. | Chief Executive Officer | 12/14/2020 | 185,000 |
| Schoenberg Mark | Chief Medical Officer | 12/04/2020 | 13,141 |
| Schoenberg Mark | Chief Medical Officer | 10/26/2020 | 2,116 |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | 10/15/2020 | 52,248 |
| Schoenberg Mark | Chief Medical Officer | 09/04/2020 | 7,030 |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | 09/01/2020 | 11,615 |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | 07/27/2020 | 3,315 |
| Schoenberg Mark | Chief Medical Officer | 07/27/2020 | 1,646 |
| Schoenberg Mark | Chief Medical Officer | 06/04/2020 | 9,602 |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | 05/20/2020 | 8,975 |
| Schoenberg Mark | Chief Medical Officer | 04/27/2020 | 1,705 |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | 04/27/2020 | 3,433 |
| Mullennix Stephen | Chief Operating Officer | 04/27/2020 | 3,531 |
| Schoenberg Mark | Chief Medical Officer | 03/04/2020 | 10,178 |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | 02/20/2020 | 10,685 |
| Mullennix Stephen | Chief Operating Officer | 02/14/2020 | 17,160 |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | 01/27/2020 | 19,530 |
| Mullennix Stephen | Chief Operating Officer | 01/27/2020 | 20,014 |
| Schoenberg Mark | Chief Medical Officer | 01/27/2020 | 9,386 |
| Schoenberg Mark | Chief Medical Officer | 12/04/2019 | 10,870 |
| Barrett Elizabeth A. | Chief Executive Officer | 11/21/2019 | 210,840 |
| Barrett Elizabeth A. | Chief Executive Officer | 11/20/2019 | 209,160 |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | 11/20/2019 | 10,057 |
| Schoenberg Mark | Chief Medical Officer | 11/19/2019 | 55,213 |
| Barrett Elizabeth A. | Chief Executive Officer | 11/15/2019 | 40,248 |
| Mullennix Stephen | Chief Operating Officer | 11/14/2019 | 15,806 |
| Schoenberg Mark | Chief Medical Officer | 09/04/2019 | 11,635 |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | 08/20/2019 | 46,827 |
| Mullennix Stephen | Chief Operating Officer | 08/15/2019 | 19,243 |
| Schoenberg Mark | Chief Medical Officer | 06/04/2019 | 12,022 |
| Mullennix Stephen | Chief Operating Officer | 05/14/2019 | 23,092 |
| Belldegrun Arie | Director | 03/27/2019 | 514,560 |
| Schoenberg Mark | Chief Medical Officer | 03/21/2019 | 10,066 |
| Cohen Fred E | Director | 02/06/2019 | 254,850 |
| Schoenberg Mark | Chief Medical Officer | 03/06/2019 | 74,264 |
| Mullennix Stephen | Chief Operating Officer | 02/14/2019 | 104,589 |
| ProQuest Investments IV, L.P. | 10% Owner | 11/28/2017 | 7,202,961 |
| ProQuest Investments IV, L.P. | 10% Owner | 11/27/2017 | 1,294,910 |
Load More Insider Transactions
FUNDS WITH A POSITION IN UROGEN PHARMA LTD
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 3,083,430 | 0.72% | 107.82% | Other |
| BLACKROCK INC. | 1,719,304 | 0.00066% | 43.56% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 312,516 | 0.00049% | 42.62% | Other |
| ARK INVESTMENT MANAGEMENT LLC | 146,329 | 0.02% | -9.41% | Growth |
| RENAISSANCE TECHNOLOGIES LLC | 91,300 | 0.00212% | -43.04% | Other |
| D. E. SHAW & CO., INC. | 77,873 | 0.00102% | 131.54% | Other |
| PALO ALTO INVESTORS LP | 24,500 | 0.03% | No change | Other |
| AQR CAPITAL MANAGEMENT LLC | 18,383 | 0.00052% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR UROGEN PHARMA LTD
STOCK BUYBACKS FOR UROGEN PHARMA LTD
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-10.72%
1Q
06/30/2023
22.90%
2Q
03/31/2023
23.86%
3Q
12/31/2022
24.87%
4Q
09/30/2022
26.48%
5Q
06/30/2022
27.00%
6Q
03/31/2022
27.41%
7Q
12/31/2021
28.53%
8Q
09/30/2021
28.84%
9Q
06/30/2021
29.12%
10Q
03/31/2021
29.64%
11Q
12/31/2020
30.18%
12Q
09/30/2020
30.72%
13Q
06/30/2020
32.55%
14Q
03/31/2020
36.28%
15Q
12/31/2019
37.33%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR UROGEN PHARMA LTD
LOADING...